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SUMMARY 
 
Biomaterial surface properties such as microtopography and energy can change 
cellular responses at the cell-implant interface.  Phospholipase D (PLD) is required for 
differentiation of osteoblast-like MG63 cells on machined and grit-blasted titanium 
surfaces.  Here, we determined if PLD is also required on microstructured/high-energy 
substrates and the mechanism involved.   
shRNAs for human PLD1 and PLD2 were used to silence MG63 cells.  Wild-type 
and PLD1 or PLD1/2 silenced cells were cultured on smooth-pretreatment surfaces (PT); 
grit-blasted, acid-etched surfaces (SLA); and SLA surfaces modified to have higher 
surface energy (modSLA).  PLD was inhibited with ethanol or activated with 24,25-
dihydroxyvitamin-D3 [24R,25(OH)2D3].  
As surface roughness/energy increased, PLD mRNA and activity increased, cell 
number decreased, osteocalcin and osteoprotegerin increased, and protein kinase C 
(PKC) and alkaline phosphatase specific activities increased.  Ethanol inhibited PLD and 
reduced surface effects on these parameters.  There was no effect on these parameters 
after knockdown of PLD1, but PLD1/2 double knockdown had effects comparable to 
PLD inhibition.  24R,25(OH)2D3 increased PLD activity and production of osteocalcin 
and osteoprotegerin, but decreased cell number on the rough/high-energy surfaces.   
These results confirm that surface roughness/energy-induced PLD activity is 
required for osteoblast differentiation and that PLD2 is the main isoform involved in this 
pathway.  Here we showed that PLD is activated by 24R,25(OH)2D3 in a surface-
dependent manner and inhibition of PLD reduced the effects of surface 
 x
 xi
microstructure/energy on PKC, suggesting that PLD mediates the stimulatory effect of 
microstructured/high-energy surfaces via PKC-dependent signaling. 
 
 
 
 
 CHAPTER 1 
INTRODUCTION 
 
1.1 Titanium Implants 
 There are greater than 300,000 hip and knee implants and 100,000-300,000 dental 
implants used each year in the United States to replace diseased or damaged tissues [1].  
Titanium (Ti) is still considered to be the best material for manufacturing skeletal 
prosthetic devices and dental implants, because of its mechanical and physical properties 
and its good biocompatibility [2-4].  The goal of current implant research is to design 
implants that induce controlled, guided, rapid healing, and better osseointegration at the 
bone-implant interface [1, 4, 5].  Osseointegration is the integration of the implant to the 
bone at the tissue-implant interface and is critically important for the long-term success 
of the implant [1, 5].    
1.2 Osteoblast Response to Ti Implant Surfaces 
 Biomaterial surface properties such as chemical composition, microtopography, 
and energy can change cellular responses at the cell-implant interface [1, 3-17].  Studies 
using titanium as a model to study osteoblast/substrate interactions show that osteoblast-
like cells attach more readily to implant surfaces with micron-scale and submicron scale 
roughness [5].  Proliferation is decreased and osteocalcin (OCN) production is increased 
on microstructured Ti surfaces [18, 19], indicating a more differentiated phenotype.  
Moreover, osteoblasts produce greater levels of factors associated with bone formation, 
vascularization, and inhibition of bone resorption [10, 20, 21].  In vitro results using these 
cell culture models are positively correlated with preclinical and clinical studies showing 
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improved bone-to-implant contact and greater pull-out strength for dental and 
orthopaedic implants [22-25]. 
Previous studies have shown that osteoblast differentiation on microstructured Ti 
involves prostaglandin production via cyclooxygenase 1 and 2 is involved [26] and 
signaling via protein kinase C (PKC) [14], as well as signaling by the α2β1 integrin [13, 
15, 27].  Recently, it was shown that MG63 cells exhibit increased phospholipase D 
(PLD) activity on sandblasted Ti surfaces and inhibition of PLD by 2,3-
diphosphoglyceric acid reduced alkaline phosphatase activity and OCN production [28], 
indicating that PLD also plays a role.   
There are two different mammalian isoforms of PLD, PLD1 and PLD2.  These 
isoforms share approximately 50% homology, but they are regulated and localized 
differently in the cell.  In vitro, PLD2 has a higher basal activity than PLD1, but overall 
the activity of PLD is low in the cell.  PLD1 is activated by protein PKCα and GTPases 
such as RhoA, RacI, Cdc42, and ADP-ribosylation factor (ARF), whereas PLD2 is not 
[29-39].  Four PLD1 splice variants, PLD1a, 1b, 1c, and 1d, have been identified 
according to the Universal Protein Resource database (UniProt), of which PLD1a and 
PLD1b have been the most studied.  PLD1b is 38 amino acids shorter than PLD1a, but 
there has been no evidence of any functional or regulatory differences between the 
variants [35, 36, 40].  PLD2 has three splice variants, PLD2a, 2b, and 2c according to the 
UniProt database.  PLD2b is a splice variant that lacks 11 amino acids in its C-terminus 
compared to PLD2a, but is still functional [40].   
The main function of PLD is to hydrolyze membrane phosphatidylcholine (PC) to 
generate the precursor signaling molecule phosphatidic acid (PA) and choline [41].  PA 
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can also be converted to lipid second messengers, such as lysophosphatidic acid (LPA) 
and diacylglycerol (DAG), which mediate the functional role of PLD.  PA can be 
metabolized into DAG by PA phosphatase, which recruits PKC to the membrane to 
activate it [29, 36, 42].  This raises the possibility that changes in PLD activity might 
mediate the effects of surface microstructure on osteoblasts via PKC or that PKC 
mediates the effects of the surface on PLD.   
 Surface energy is another surface property that impacts osteoblast response to 
their substrate.  The oxide layer that forms spontaneously over the Ti surfaces is highly 
hydrophilic and thus exhibits a high surface energy.  It is thought that the increased 
wettability in these high surface energy implant surfaces will improve the interaction 
between the biological environment and implant surface, because surface energy can 
mediate protein adsorption, which can regulate cell adhesion, and the –OH and –O-2 
groups in the oxide layer are important for hydroxyapatite (main bone mineral) formation 
and thus could enhance osseointegration [3, 16].  In vitro studies have shown that surface 
energy can enhance osteoblast differentiation and maturation, and that this effect is 
additive and in some cases synergistic with the effects of surface microstructure [3, 7, 
16].  Whether the same mechanisms mediate the effects of microstructure and surface 
energy on osteoblasts is not known.       
1.3 Specific Aims and Significance 
 The objective of this study was to determine whether microstructured/high energy 
surfaces increase osteoblast differentiation via a PLD-dependent mechanism.  To 
accomplish this, in Aim 1, we examined PLD expression and activity in MG63 cells 
grown on microstructured Ti substrates with hydrophobic and hydrophilic surfaces and 
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we determined which PLD isoform was responsible for the effects on osteoblast 
differentiation.  PLD activity was inhibited using ethanol and the contributions of specific 
isoforms were determined using RNA interference.  In Aim 2, we examined the 
hypothesis that PLD mediates the effects of the surface via PKC.  In Aim 3, we took 
advantage of a previous observation showing that PLD-dependent PKC can be activated 
by 24R,25(OH)2D3 in growth plate chondrocytes [43, 44] and used 24R,25(OH)2D3 to 
stimulate PLD activity in the MG63 cells grown on microstructured/high energy surfaces.  
 The significance of this in vitro study has the potential to help elucidate the 
signaling events occurring at the cell-implant interface and thus help to further 
understand the mechanism involved in osseointegration.  A better understanding of how 
the cells are responding to the surfaces will allow researchers to possibly tailor implants 
through surface modification by physical means or coatings with growth 
factors/hormones or polymers, to induce these responses. 
 
 
 4
CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Cell Culture and Ti Surfaces 
 MG63 human osteoblast-like cells were obtained from the American Type 
Culture Collection (Rockville, MD).  MG63 cells have been shown to be comparable to 
immature osteoblasts [6, 11, 14].  MG63 cells were cultured in 24-well plates on tissue 
culture polystyrene (TCPS) and on three types of 15 mm diameter Ti disks.  Smooth 
pretreatment surfaces (PT) had a mean peak to valley roughness (Ra) of 0.2 μm and acid-
etched/sand-blasted surfaces (SLA) had an average roughness of 3.2 μm.  In addition, 
SLA surfaces were fabricated so that they retained high surface energy without altering 
the SLA microstructure (modSLA).  These disks were provided by Institut Straumann 
AG (Basel, Switzerland) and were previously characterized [16, 45]. 
 MG63 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37°C in an 
atmosphere of 5% CO2 and 100% humidity.  Cells were plated at a density of 10,000 
cells/cm2 for all surfaces.  The media were replaced at 24 hours and then every 48 hours 
until the cells reached confluence on TCPS.  Primary alcohols such as ethanol (EtOH) are 
known PLD inhibitors [29, 36, 46-50].  Because 24R,25(OH)2D3 is suspended in EtOH, 
in order to use it as an activator of PLD activity, it was necessary to remove EtOH by 
evaporation and then resuspend 24R,25(OH)2D3 in tert-butanol, a commonly used alcohol 
control that does not inhibit PLD activity or cause cell toxicity [47-51].  At confluence, 
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the cells were treated with experimental media containing 0.01% EtOH, vehicle (0.01% 
tert-butanol), or 24R,25(OH)2D3 (Biomol International, L.P., Plymouth Meeting, PA) at 
10-8 and 10-7M for 24 hours.  For each experiment, each variable was tested using six 
separate disks.   
 Conditioned media were collected and the cells were released from the surfaces 
by two sequential incubations with 0.25% trypsin-EDTA for 10 minutes at 37°C, to 
ensure removal of the cells from the Ti substrates.  Cells were counted using an automatic 
cell counter (Z1 cell and particle counter, Beckman Coulter, Fullerton, CA).  The cells 
were pelleted by centrifugation and then resuspended with the PLD reaction buffer from 
Invitrogen’s Amplex® Red PLD assay kit (Carlsbad, CA), containing 50mM Tris-HCl, 
5mM CaCl2, and pH at 8.0.  The cells were then lysed by sonication for five seconds for 
four times while on ice and saved for further biochemical analysis. 
2.2 Biochemical Assays  
 Two osteoblast differentiation markers were assessed in these studies, alkaline 
phosphatase and osteocalcin.  Alkaline phosphatase specific activity was assayed by 
measuring the release of p-nitrophenol from p-nitrophenylphosphate at pH 10.2 [52].  
Osteocalcin content in the conditioned media was measured using a commercially 
available radioimmunoassay kit (Human Osteocalcin RIA Kit, Biomedical Technologies, 
Inc, Stoughton, MA).  The amount of osteoprotegerin (OPG) in the conditioned media 
was measured using an enzyme-linked immunosorbent assay (ELISA) kit (DY805 
Osteoprotegerin DuoSet, R&D Systems, Minneapolis, MN).   
 PKC activity in the cell lysates was measured using a commercially available 
assay kit that detects the amount of radiolabeled phosphate transferred to a peptide 
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specific for PKC (PKC Biotrak Enzyme Assay System, GE Healthcare Life Sciences, 
Pittsburgh, PA).  PLD activity in the cell lysates was measured using a fluorescence assay 
that detects the release of choline from phosphatidylcholine (Amplex® Red PLD Assay 
Kit, Invitrogen, Carlsbad, CA).  In addition, a PLD standard was made with PLD from 
Streptomyces chromofuscus (Sigma-Aldrich, St. Louis, MO) to assess the activity in the 
samples.   
 The manufacturer’s instructions were followed for all assays.  The levels of 
osteocalcin and osteoprotegerin in the conditioned media were normalized by cell 
number, while alkaline phosphatase, PKC, and PLD activity in the cell lysates were 
normalized by protein content.  Protein content was determined in the cell lysates using 
the bicinchoninic acid (BCA) protein assay (Thermo Fisher Scientific Inc, Rockford, IL). 
2.3 Real Time PCR Analysis of PLD Expression 
 To determine if there was a change in the expression level of PLD1a, 1b, 2a, and 
2b, the mRNA was quantified by real time PCR.  MG63 cells were cultured on the Ti 
disks in the same manner as above.  RNA was extracted using Qiagen’s RNeasy kit 
(Valencia, CA).  Three disks of each type were combined to form one sample.   
 One microgram of RNA was reversed transcribed with 1µM each of the antisense 
primers in a 7µl volume using the Qiagen Omniscript RT kit (Valencia, CA).  Part of the 
control cDNA reaction was purified using the Qiagen Qiaquick PCR purification kit 
(Valencia, CA) to make a standard (a series of dilutions) for real time PCR; this was 
designed to be the calibrator so that PLD gene expression levels of the unknown samples 
could be compared after normalization by their respective GAPDH expression levels.  
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 The PLD1a, 1b, 2a, and 2b primer sequences were based on sequences from 
GenBank accession numbers NM_002662, AB209907, NM_002663, and AF038441 
respectively.  In addition to obtaining a single peak in the melt curve for each of these 
primers (indicating a single PCR product) for the real time PCR optimization, reverse 
transcription PCR was also done and the products were run on agarose gels to ensure that 
a single band at the correct size was obtained.  Table 1 shows the primer sequences and 
the optimized conditions for real time PCR using SYBR green incorporation (iQ SYBR 
Green Supermix, Biorad Laboratories, Hercules, CA) in a Biorad iCycler iQ real time 
system.  No additional MgCl2 was added to the real time PCR amplification reactions; the 
1x SYBR Green Supermix contained 3mM MgCl2. 
 
 
Table 1. Real time PCR PLD primer sequences and optimal conditions 
 PLD1a PLD1b PLD2a PLD2b 
Sense primer 
sequence  
(5’ ? 3’) 
 
GAA AGT TCT CCA 
AAT TTA GTC 
 
GCA CCT CCA ATA 
CCG GGT 
 
AAT GAC CGG AGC 
TTG CTG 
 
AAT GAC CGG AGC 
TTG CTG 
Antisense primer 
sequence  
(5’ ? 3’) 
 
GGA TTA AAT TGT 
GAT GAC TTC 
 
AGT TGA ACC CAG 
TCT TTG AAG 
 
GCA GAC TCA AGG 
CAA ACC TG 
 
AGA ATC ACA CTG 
CCC GCC 
[Sense primer] 
(µM) 
0.16 0.20 0.20 0.16 
[Antisense primer] 
(µM) 
0.16 0.20 0.20 0.16 
1:10 cDNA 
dilution (µl) 
3.0 3.0 3.0 3.0 
Annealing 
Temperature (°C) 
59.4 62.5 62.5 53.4 
Cycles 40 40 40 40 
 
 
 8
2.4 PLD1 and PLD2 shRNAs 
 To determine if there was a specific PLD isoform involved in the signaling at the 
cell-implant interface, three small hairpin RNAs for each PLD isoform were tested to 
determine the best overall knockdown of gene and protein expression.  PLD1 shRNA 
sequences were based on the GenBank accession number NM_002662 PLD1 sequence 
(Table 2).  PLD2 shRNA sequences were based on the GenBank accession number 
NM_002663 PLD2 sequence (Table 2).  These sequences were put into lentivirus vectors 
containing the puromycin resistance gene and were packaged in Mission® shRNA 
Lentiviral Particles, which were purchased from Sigma-Aldrich (St. Louis, MO).  The 
shRNA containing lentiviral particles were transduced in MG63 cells to produce stable 
PLD1 and PLD2 shRNA cell lines through puromycin selection. 
 
 
Table 2. PLD1 and PLD2 shRNA hairpin sequences 
ID PLD isoform Sequence 
A1 PLD1 CCG GGC AAG TTA AGA GGA AAT TCA ACT CGA 
GTT GAA TTT CCT CTT AAC TTG CTT TTT 
A2 PLD1 CCG GGC ATT CTC GTA TCC AAC CCA ACT CGA GTT 
GGG TTG GAT ACG AGA ATG CTT TTT 
A3 PLD1 CCG GCC ACT AGA AGA CAC ACG TTT ACT CGA 
GTA AAC GTG TGT CTT CTA GTG GTT TTT 
G1 PLD2 CCG GCC GAA AGA TAT ACC AGC GGA TCT CGA 
GAT CCG CTG GTA TAT CTT TCG GTT TTT G 
G2 PLD2 CCG GCC TCT CTC ACA ACC AAT TCT TCT CGA GAA 
GAA TTG GTT GTG AGA GAG GTT TTT G 
G3 PLD2 CCG GCG ATG AGA TTG TGG ACA GAA TCT CGA 
GAT TCT GTC CAC AAT CTC ATC GTT TTT G 
 
 Reverse transcription PCR (RT-PCR), Western blotting, and PLD activity were 
used to assess the effectiveness of the knockdown of each shRNA clone.  RNA was 
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extracted using Trizol (Invitrogen, Carlsbad, CA) and was subjected to RT-PCR with 
human PLD1a/b, PLD2a/b, and GAPDH primers.  PLD1a/b and PLD2a/b primer 
sequences and RT-PCR conditions were from Di Fulvio et al [53].  One microgram of 
RNA was reversed transcribed with 1µM each of the antisense primers in a 7µl volume 
using the Qiagen Omniscript RT kit.  The PCR reaction was composed of 1x PCR buffer 
B (Fisher Scientific, Pittsburgh, PA), 0.2mM dNTPs (Qiagen, Valencia, CA), 1mM 
MgCl2 (Fisher Scientific), 0.625 units of Taq polymerase (Qiagen), and 1µM each of the 
reverse and forward primers in a reaction volume of 25µl.  PCR amplification was carried 
out in a Biorad iCycler (Hercules, CA).  PCR products for PLD1a/b were run on 2% 
agarose gel, while PCR products for PLD2a/b were run on 3% agarose gel to get better 
separation of the PLD2a and 2b splice variants.  Density measurements of the PCR 
product bands were measured to determine the percent of control for each PLD shRNA 
clone (after normalization by their respective GAPDH densities).   
 For Western blotting, whole cell lysates (WCL) were harvested from cultures of 
PLD shRNA transduced cells that were grown to confluence similarly to the control non-
transduced MG63 cells except with the addition of 0.25µg/mL puromycin to maintain 
selection.  A lysis solution composed of 20mM Tris-HCl, 150mM NaCl, 5mM EDTA, 
1% Nonidet P-40, and pH of 7.5, was used to lyse the cells.  The cells were further lysed 
by sonication for fifteen seconds for two times in one minute intervals while on ice.  
Protein content was determined using the BCA protein assay.  Fifty micrograms of 
protein of each WCL clone were run on 4-20% Tris-HEPES-SDS polyacrylamide gels 
(NuSep Inc, Lawrenceville, GA) and were transferred to nitrocellulose using Invitrogen’s 
iblot transfer system (Carlsbad, CA).  The blots were probed with PLD1 (Sigma-
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Aldrich), PLD2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and GAPDH 
(Millipore, MA) antibodies.  Secondary antibodies conjugated with horseradish 
peroxidase were purchased from Biorad Laboratories (Hercules, CA) and incubated with 
the blots for the chemiluminescent reaction.  Blots were developed using the SuperSignal 
West Pico Chemiluminescent System (Thermo Fisher Scientific Inc., Rockford, IL). 
 For PLD activity, cells were cultured to confluence similarly as for the Western 
blot and harvested using 0.25% trypsin-EDTA to release the cells.  Cells were pelleted by 
centrifugation and then resuspended with the PLD reaction buffer from Invitrogen’s 
Amplex® Red PLD assay kit.  The cells were then lysed by sonication for five seconds 
for four times while on ice.  The Amplex® Red PLD assay kit was used to determine the 
PLD activity in the cell lysates, with the addition of a PLD standard made with PLD from 
Streptomyces chromofuscus to assess the activity in the samples. 
 After determination of the best PLD1 and PLD2 shRNAs, the transduced cell 
lines and the control non-transduced MG63 cells were cultured on the Ti disks in the 
same manner as previously stated above and subjected to the same biochemical assays.  
2.5 Statistical Analysis 
The data presented here are from one of two separate sets of experiments, both of 
which yielded comparable observations.  For any given experiment, each data point 
represents the mean ± standard error of six individual cultures or six separate samples.  
Data were first analyzed by analysis of variance; when statistical differences were 
detected, the Bonferroni modification of Student’s t-test was used.  p-Values < 0.05 were 
considered to be significant. 
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CHAPTER 3 
RESULTS 
 
3.1 Effect of Microstructured and High Energy Ti Surfaces on PLD 
Cell number decreased (Fig 1B) and osteocalcin (Fig 1C) increased in cultures 
grown on SLA in comparison with cells grown on TCPS or smooth Ti.  These effects 
were further increased when MG63 cells were cultured on modSLA.  PLD specific 
activity exhibited a comparable substrate-dependent response (Fig 1A).  Activity was 
increased by 100% on SLA and by more than 200% on modSLA.  Similarly, PKC 
activity was substrate dependent (Fig 1D), but significant increases in activity were 
observed on modSLA only.  
 
 
 12
 Figure 1. (A) PLD activity, where 1 unit (U) of PLD will liberate 1.0μM of choline from 
L-α-phosphatidylcholine (egg yolk) per hour at pH 8.0 at 30°C, (B) cell number, (C) 
amount of osteocalcin, and (D) PKC activity in MG63 cells cultured on TCPS, PT, SLA, 
and modSLA Ti surfaces.  * TCP vs surfaces p<0.05; ^ PT vs surfaces p<0.05; # SLA vs 
modSLA p<0.05. 
 
 
 
 
 Overall, PLD expression reflected a similar trend as the PLD activity, although 
the splice variants were differentially expressed.  PLD1a was elevated on SLA and to a 
much greater extent on modSLA (Fig 2A).  PLD1b mRNAs were increased on all Ti 
surfaces, but the greatest increase was in cultures grown on modSLA (Fig 2B).  
Similarly, PLD2a mRNAs were elevated on all Ti substrates, but there were no 
differences as a function of microstructure or surface energy (Fig 2C).  Finally, PLD2b 
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was increased only on SLA and modSLA and this increase was comparable on both 
surfaces (Fig 2D).   
 
 
 
 
 
Figure 2. (A) PLD1a, (B) PLD1b, (C) PLD2a, and (D) PLD2b expression in MG63 cells 
cultured on TCPS, PT, SLA, and modSLA Ti surfaces.  * TCP vs surfaces p<0.05; ^ PT 
vs surfaces p<0.05; # SLA vs modSLA p<0.05. 
 
 
 
 
3.2 Requirement for PLD in Osteoblast Response 
Treatment of confluent cultures of MG63 cells with the PLD inhibitor ethanol, 
had no effect on PLD activity in cultures grown on TCPS, but it reduced PLD activity on 
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all Ti substrates to levels below those seen on the plastic substrates (Fig 3A).  PLD did 
not mediate the inhibitory effect of surface roughness or surface energy on cell number, 
since inhibition of enzyme activity with ethanol had no effect (Fig 3B).  However, PLD 
was involved in the substrate-dependent expression of a differentiated phenotype and the 
effects were substrate specific.  Ethanol treatment reduced alkaline phosphatase activity 
on TCPS and PT to a similar extent (Fig 3C).  Ethanol reduced alkaline phosphatase in 
cell layer lysates grown on SLA to levels below those seen in cells grown on TCPS.  
Similarly, ethanol reduced the synergistic increase in alkaline phosphatase seen on 
modSLA surfaces, but the inhibitory effect was only to levels seen in untreated cultures 
on SLA.  Similarly, ethanol blocked the increase in osteocalcin production due to growth 
on SLA and caused a partial reduction in osteocalcin production by cells grown on 
modSLA (Fig 3D).  This was the case for osteoprotegerin as well (Fig 3E).  PKC activity 
was increased in MG63 cells grown on PT in the presence of ethanol, but ethanol had no 
effect on PKC in cells grown on SLA (Fig 3F).  In contrast, ethanol completely blocked 
the synergistic effects of surface microstructure and surface energy on PKC activity in 
cells grown on modSLA. 
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 Figure 3. (A) PLD activity, where 1 U of PLD will liberate 1.0μM of choline from L-α-
phosphatidylcholine (egg yolk) per hour at pH 8.0 at 30°C, (B) cell number, (C) alkaline 
phosphatase activity, (D) amount of OCN, (E) amount of OPG, and (F) PKC activity in 
MG63 cells cultured on TCPS, PT, SLA, and modSLA Ti surfaces after 24 hour 
treatment with 0.01% EtOH.  * No treatment vs treatment p<0.05; ^ TCP vs surfaces 
p<0.05; $ PT vs surfaces p<0.05; # SLA vs modSLA p<0.05. 
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3.3 PLD1 and PLD2 shRNA 
 Stably transduced cell lines were established that exhibited >70% knockdown in 
PLD1 expression (Fig 4A).  Three PLD1 shRNA clones (A1, A2, and A3) were screened 
and they expressed 26%, 22%, and 32% of the control (non-transduced MG63 cells) 
PLD1a mRNA expression, respectively.  They expressed 46%, 39%, and 50% of the 
control PLD1b mRNA expression respectively.  PLD2a and PLD2b expression for clones 
A1 and A2 were similar to the control.  However, A3 had an 80% increase in PLD2a and 
a 65% increase in PLD2b expression compared to the control.  The Western blot for the 
PLD1 clones correlated with the RT-PCR results, with the exceptions of a slight 
reduction in band intensity for PLD2 protein expression in A1 and a large reduction in 
band intensity for PLD2 protein expression in A2 (Fig 4B).  HeLa WCLs were used as a 
positive control for PLD1 and PLD2.  A1, A2, and A3 clones were significantly lower 
than the PLD activity in the control (Fig 4C).   
 The PLD2 shRNA clones, G1, G2, and G3, were 34%, 30%, and 65% of the 
control PLD1a mRNA expression, respectively, and were 50%, 53%, and 62% of the 
control PLD1b mRNA expression respectively (Fig 4D).  G1, G2, and G3 clones were 
79%, 30%, and 56% of the control PLD2a mRNA expression respectively, and were 
69%, 26%, and 34% of the control PLD2b mRNA expression respectively.  The Western 
blot for the PLD2-silenced cells correlated with the RT-PCR results, with the exceptions 
of a reduction in band intensity for PLD2 protein expression in G1 and an increase in 
band intensity for PLD2 protein expression in G3 (Fig 4E).  G1, G2, and G3-silenced 
cells had significantly lower PLD activity than in the control cells (Fig 4F).   
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Figure 4. (A) and (D) are the band density measurements (% control) of PLD1a, 1b, 2a, 
and 2b, and agarose gel images of the RT-PCR on PLD1 (A1, A2, and A3) and PLD2 
(G1, G2, and G3) shRNA clones respectively with PLD1a/b, PLD2a/b, and GAPDH 
primers.  (B) and (E) are the Western blots on PLD1 and PLD2 shRNA WCLs 
respectively that were probed with PLD1, PLD2, and GAPDH antibodies.  HeLa WCLs 
were used as a positive control for PLD1 and PLD2.  (C) and (F) are graphs of the PLD 
activity in the PLD1 and PLD2 shRNA cell lysates respectively.  * Control vs PLD 
shRNA p<0.05.  
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 Based on these results, A3 and G2 were selected to knockdown PLD1 and 
PLD1/2 expression respectively.  Only cells transduced with PLD1/2 shRNA exhibited 
decreased PLD activity and the effect of the shRNA was to reduce this activity to a 
comparable level in all cultures, including those grown on TCPS (Fig 5A).  PLD1-
silenced cells exhibited a small decrease in cell number on TCPS, but PLD1 silencing did 
not affect cell number on the Ti substrates (Fig 5B).  In contrast, PLD1/2 shRNA caused 
an increase in cell number on all Ti substrates.  In cultures grown on PT and SLA, 
silencing PLD1/2 restored cell number to levels seen on TCPS, but in cells grown on 
modSLA, restoration of cell number was only partial.  PLD silencing also affected 
osteoblast differentiation.  PLD1 silenced cells exhibited a 20-25% decrease in alkaline 
phosphatase activity on all substrates, but PLD1/2 silenced cells exhibited a 75% 
reduction in enzyme activity (Fig 5C).  Only PLD1/2-silenced cells had decreased 
osteocalcin (Fig 5D) and decreased osteoprotegerin (Fig 5E).  PLD1-shRNA reduced 
PKC activity in cells grown on TCPS, SLA and modSLA (Fig 5F).  In contrast, PLD1/2 
shRNA reduced PKC on PT, SLA and modSLA but did not affect enzyme activity on 
TCPS.  
 
 
 19
 
 
Figure 5. (A) PLD activity, where 1 U of PLD will liberate 1.0μM of choline from L-α-
phosphatidylcholine (egg yolk) per hour at pH 8.0 at 30°C, (B) cell number, (C) alkaline 
phosphatase activity, (D) amount of OCN, (E) amount of OPG, and (F) PKC activity in 
control MG63 cells, PLD1 shRNA silenced cells, and PLD1/2 shRNA silenced cells 
cultured on TCPS, PT, SLA, and modSLA Ti surfaces.  * TCP vs surfaces p<0.05; ^  PT 
vs surfaces p<0.05; & SLA vs modSLA p<0.05; # Control vs PLD1 or PLD1/2 shRNA 
p<0.05; $ PLD1 shRNA vs PLD1/2 shRNA p<0.05. 
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3.4 Effect of PLD Activation by 24R,25(OH)2D3 
24R,25(OH)2D3 decreased PLD activity on PT, but had no effect on PLD on SLA, 
and caused an increase in PLD activity on modSLA (Fig 6A).  The inhibitory effect on 
PT was only at the highest concentration of 10-7 M and the stimulatory effect on modSLA 
was achieved at 10-8 M.  24R,25(OH)2D3 reduced cell number in cultures grown on SLA 
by 50% and had a similar percent reduction in cultures grown on modSLA (Fig 6B).  The 
decrease in cell number was correlated with a corresponding increase in osteocalcin (Fig 
6C) and osteoprotegerin (Fig 6D).  
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 Figure 6. (A) PLD activity, where 1 U of PLD will liberate 1.0μM of choline from L-α-
phosphatidylcholine (egg yolk) per hour at pH 8.0 at 30°C, (B) cell number, (C) amount 
of OCN, and (D) amount of OPG from MG63 cells cultured on TCPS, PT, SLA, and 
modSLA Ti surfaces after treatment with vehicle, 10-8M, and 10-7M 24,25 for 24 hours. * 
TCP vs surfaces p<0.05; ^  PT vs surfaces p<0.05; & SLA vs modSLA p<0.05; # Vehicle 
vs 24,25 treatment p<0.05; $ 10-8 M 24,25 vs 10-7 M 24,25 p<0.05.    
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CHAPTER 4 
DISCUSSION AND CONCLUSIONS 
 
4.1 Discussion 
 This study shows that PLD plays an important role in mediating the response of 
osteoblasts to surface microstructure and to surface energy.  Both PLD1 and PLD2 are 
involved, but they participate in a differential manner depending on the substrate and on 
the outcome being measured.  Finally, these results show that PLD signaling is 
responsible for substrate dependent changes in PKC signaling and that 24R,25(OH)2D3 
can be a regulator of this pathway. 
 MG63 cells expressed four PLD isoforms/variants, PLD1a, PLD1b, PLD2a and 
PLD2b based on mRNA and Western blot.  Expression of all the variants was increased 
on the rougher and higher energy surfaces.  However, PLD1a and PLD1b expression 
were significantly higher on the modSLA compared to the SLA surface, while PLD2a 
and PLD2b expression was not sensitive to surface energy and was equivalent to the 
expression level on the rough SLA surface.  This observation suggested the possibility 
that PLD1 mediated the effects of surface energy, but experiments using specific shRNAs 
for PLD1 did not support this hypothesis. 
 We successfully silenced PLD1 expression without affecting PLD2 expression 
and activity, but we were not able to achieve effective silencing of PLD2 without 
affecting PLD1.  The PLD2 shRNA clones had a suppressive effect on PLD1 expression 
and two of the three clones were ineffective in knocking down PLD2 expression.  One 
possible explanation for the PLD1 suppression is sequence homology.  The PLD2 
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shRNA sequences were aligned to the PLD1 sequence (GenBank accession number 
NM_002662) using the free shareware program BioEdit Sequence Alignment Editor 
(Carlsbad, CA).  The alignment revealed a similarity in sequence between the PLD2 
shRNAs and PLD1 sequence.  However, since the G2 clone knocked down PLD1 and 
PLD2 expression effectively, this provided a double knock down of both major PLD 
isoforms and would still allow us to determine which PLD isoform was mediating the 
surface effect, because we also had a PLD1 specific shRNA (A3).  Therefore, we chose 
the G2 clone as our PLD1/2 shRNA to do further experiments on the rough and high 
energy surfaces and by comparing results examining the responses of PLD1-silenced 
cells to those of the PLD1/2 silenced cells, we were able to assess the contribution of 
PLD2 to osteoblast response. 
 Our results confirmed previous studies using machined and grit blasted Ti 
substrates, which reported an increase in PLD activity in MG63 cells grown on rough 
surfaces over that seen in osteoblast cultures grown on TCPS [28].  The earlier study 
showed that PLD was required for the increase in osteoblast differentiation observed on 
the machined and grit blasted substrates since inhibition of the enzyme blocked the effect, 
and determined that PLD1 was responsible.  The present study extends these observations 
to show that PLD1 is also required for osteoblast differentiation on microstructured 
surfaces produced by acid-etched, grit blasted Ti surfaces and, importantly, shows that 
PLD2 is involved in the synergistic response to high surface energy on the 
microstructured surface.   
 PLD did not mediate all effects of substrate microstructure or surface energy, nor 
were those responses in which PLD did play a role regulated by the enzyme to a similar 
 24
extent.  Even though treatment with ethanol reduced PLD activity in cultures grown on Ti 
to levels below those seen on TCPS, PLD inhibition had no effect on cell number, either 
on smooth or rough substrates.  Alkaline phosphatase activity was reduced on all 
substrates, suggesting that PLD mediated early events in osteoblast differentiation.  This 
hypothesis was supported by the observation that PLD-inhibition only reduced 
osteocalcin and osteoprotegerin in cultured grown on SLA and modSLA.  Moreover, the 
reduction was comparable on both surfaces and was only partial.  This indicates that PLD 
was only required for the response to surface roughness and not for the response to 
surface energy, at least with respect to these two osteoblast factors.   
 Although PLD1-shRNA reduced PLD1 mRNA and activity by 70% in cells 
grown on TCPS, the PLD1-shRNA silenced MG63 cells did not exhibit reduced activity 
when they were grown on the Ti substrates.  In contrast, the PLD1/2-silenced cells had 
PLD activity comparable to cells grown on TCPS, indicating that PLD2 was the isoform 
responsive to surface energy.  One possible explanation for why there was no reduction 
in PLD activity in the PLD1-shRNA cells on the control surfaces is that the cells may 
have produced more PLD2 to compensate for the PLD1 knockdown, which is supported 
by our mRNA expression results (in our screening process) where there was an 80% and 
65% increase in PLD2a and PLD2b expression respectively in the PLD1 shRNA clone 
A3 (the clone used in this surface study).   
 The combined knockdown of PLD1/2 caused a partial increase in cell number on 
the SLA and modSLA substrates and reduced osteocalcin and osteoprotegerin on all Ti 
substrates, supporting the hypothesis that PLD2 was responsible for these surface-
dependent effects.  That PLD2 was the main isoform involved in the surface roughness 
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and energy induced PLD activity is somewhat contradictory to the mRNA expression 
results, where we saw that PLD1a and PLD1b expression was sensitive to surface energy, 
while PLD2a and PLD2b expression was not.  It is possible that not all of the mRNA was 
translated into protein that was functional, so these results don’t necessarily have to 
correlate.  Moreover, the results of PLD1/2 knock down confirmed the PLD inhibitor 
results.   
 The fact that alkaline phosphatase activity was regulated by PLD1 and to a greater 
extent by PLD1/2, suggests that each isoform mediated a separate signaling pathway.  
Our results indicate that PLD differentially regulates PKC in a substrate-dependent 
manner.  Inhibition of PLD stimulated PKC activity in cells grown on the smooth PT 
surface to levels comparable to those seen in cells grown on the SLA surface, while 
reducing the synergist increase on the modSLA substrate to levels see on the SLA 
surface.  Based on the assumption that the surface energy effect was mediated by PLD2, 
it is likely that PLD2 is responsible for the marked increase in PKC seen in cells grown 
on modSLA.  PLD1 also acts via PKC, however, based on the small, but significant 
decrease in PKC activity observed in PLD1-silenced cells grown on TCPS, SLA, and 
modSLA.  Interestingly, PLD1 has been shown to be regulated by PKCα [54], suggesting 
that PKC may act at numerous stages during osteoblastic differentiation and that more 
than one isoform of PKC may be involved.  In the present study, we did not determine 
which PKC isoform was stimulated by surface energy or which isoform was sensitive to 
PLD1 or PLD2 activation. 
It is likely that PLD activated PKCα at least to some extent. 24R,25(OH)2D3 
caused an increase in PLD activity in cells grown on modSLA and this was associated 
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with decreased cell number and increased osteocalcin and osteoprotegerin, indicating 
increased osteoblastic differentiation.  Previously we showed that 24R,25(OH)2D3 
decreases cell proliferation and stimulates alkaline phosphatase in growth plate 
chondrocytes via PLD2-dependent PKCα signaling [43, 44, 55-57].  These observations 
suggest that it may act this way in osteoblasts as well.  The stimulatory effect of 
24R,25(OH)2D3 on PLD, osteocalcin and osteoprotegerin as well as the inhibitory effect 
on cell number were comparable on SLA and modSLA, indicating that it mediated 
response to microstructure rather than surface energy.  
 4.2 Conclusions 
 In summary, we showed that PLD is involved in the regulation of osteoblast 
differentiation on rough and high energy Ti surfaces.  In general, the higher surface 
energy Ti surface (modSLA) caused a significantly larger cell response than the other 
surfaces, thus showing the importance of surface chemistry.  Surface roughness and 
energy induced PLD activity was positively correlated with osteoblast differentiation.  
Moreover, inhibition of PLD partially blocked this effect, indicating a role for PLD in the 
process, but also suggesting that there may be other pathways regulating osteoblast 
differentiation on the rough and high energy surfaces.  Furthermore, we showed that PKC 
is regulated by surface roughness and energy induced PLD, suggesting that PKC is 
downstream from PLD, and indicating that PLD2 is the main isoform involved in this 
pathway.  We further confirmed that the main PLD isoform involved in this pathway was 
PLD2 with PLD isoform specific shRNAs.  We also reconfirmed the PLD inhibitor 
results by double knock down of PLD1 and PLD2 expression.  We showed that PLD is 
activated by the vitamin D metabolite, 24R,25(OH)2D3, in a surface dependent manner, 
possibly by a similar pathway that exists in resting zone chondrocytes and that it 
enhanced osteoblast differentiation. 
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 For future possible studies to further expand on this mechanism, it would be 
interesting to see how 24,25 is activating PLD or if other factors are regulating PLD 
upstream.  Is it through α2/β1 integrin heterodimer signaling?  Osteoblasts interact with 
the surface initially via integrin binding.  The α2/β1 integrin heterodimer binds to type I 
collagen, the major bone matrix protein.  It has been shown that α2 and β1 integrin 
expression increases on rough Ti surfaces compared to the control tissue culture 
polystyrene surface [13], and the knock down of the β1 integrin resulted in reduced 
ALPase activity and production of OCN, indicating that osteoblast differentiation 
depends on the α2/β1 integrin heterodimer [15].  Could the phospholipid, PIP2, be 
involved in binding PLD and bringing it to the membrane for activation by 24,25?  PIP2 
is required for PLD activation, but it is not known how this occurs [33, 36, 37].   
 There is still a lot of work to be done in investigating this mechanism.  This study 
aimed at looking at the signaling pathway in osteoblast differentiation on rough and high 
energy surfaces through PLD.  We established that PLD is involved in regulating 
osteoblast differentiation on rough and high energy surfaces.  This study is relevant, 
because determining what signaling pathways are occurring at the cell-implant interface 
will allow researchers to understand the cell responses in osseointegration and apply new 
technologies to reduce implant failure rates.     
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